World's Best Scientists 2026 revealed!
Rodolphe Thiébaut

Rodolphe Thiébaut

D-Index & Metrics

Microbiology

D-Index
73
Citations
23518
World Ranking
1632
National Ranking
97

Overview

Rodolphe Thiébaut is affiliated with the University of Bordeaux in France and has made significant contributions to the field of medicine, with a focus on infectious diseases. Their research encompasses several subfields such as infectious diseases, molecular biology, epidemiology, modeling and simulation, as well as statistics and probability.

Thiébaut's work spans multiple topics, notably including:

  • COVID-19 epidemiological studies
  • SARS-CoV-2 and COVID-19 research
  • Viral infections and outbreaks research
  • COVID-19 clinical research studies
  • Single-cell and spatial transcriptomics
  • Immunotherapy and immune responses
  • Data-driven disease surveillance

They have frequently published in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Zenodo (CERN European Organization for Nuclear Research)
  • Nature Communications
  • Research Square
  • arXiv (Cornell University)

Thiébaut has co-authored numerous papers with recurring collaborators including Boris P. Hejblum, Mélanie Prague, Christine Lacabaratz, Yves Lévy, and Aurélie Wiedemann.

Among their recent publications are:

  • Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial (2020, The Lancet Infectious Diseases)
  • CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death (2021, iScience)
  • Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data (2021, Nature Communications)
  • Long-lasting severe immune dysfunction in Ebola virus disease survivors (2020, Nature Communications)
  • Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa (2021, PLoS Medicine)

Best Publications

  • Combination antiretroviral therapy and the risk of myocardial infarction

    Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte

  • Class of antiretroviral drugs and the risk of myocardial infarction.

    Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber

  • Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study

    Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut

  • Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination

    David Furman;Boris P. Hejblum;Noah Simon;Vladimir Jojic

  • Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.

    Smith C;Sabin Ca;Lundgren Jd

  • Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

    Alfredo Alberti;Nathan Clumeck;Simon Collins;Wolfram Gerlich

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment

    Yves Levy;Christine Lacabaratz;Laurence Weiss;Jean-Paul Viard

  • Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

    Nina Friis-Møller;Rodolphe Thiébaut;Peter Reiss;Rainer Weber

  • Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.

    May M;Sterne Ja;Sabin C;Costagliola D

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  • The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D : A : D Study

    M G Law;N Friis-Møller;W M El-Sadr;R Weber

  • Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

    M Law;N Friis-Møller;R Weber;P Reiss

  • Effectiveness of disease-management programs for improving diabetes care: a meta-analysis

    C Pimouguet;M Le Goff;R Thiebaut;JF Dartigues

  • Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

    Benoît Marin;Rodolphe Thiébaut;Heiner C. Bucher;Virginie Rondeau

  • Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

    Y. Lévy;I. Sereti;G. Tambussi;J. P. Routy

  • Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

    Elise Arrivé;Marie-Louise Newell;Didier K Ekouevi;Marie-Laure Chaix

  • Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.

    Charles Cazanave;Michel Dupon;Valérie Lavignolle-Aurillac;Nicole Barthe

  • Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

    Collins C Iwuji;Collins C Iwuji;Joanna Orne-Gliemann;Joseph Larmarange;Eric Balestre

  • Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines

    Sara Lodi;Andrew Phillips;Giota Touloumi;Ronald Geskus

Frequent Co-Authors

Geneviève Chêne
Geneviève Chêne University of Bordeaux
François Dabis
François Dabis University of Bordeaux
Daniel Commenges
Daniel Commenges University of Bordeaux
Peter Reiss
Peter Reiss University of Amsterdam
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Caroline Sabin
Caroline Sabin University College London
Philippe Morlat
Philippe Morlat University of Bordeaux
Fabrice Bonnet
Fabrice Bonnet University of Rennes
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Andrew N. Phillips
Andrew N. Phillips University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career paths, some of which intersect with the expanding healthcare and information management sectors. For those interested in combining biological sciences with administrative skills, becoming a certified professional coder (CPC) is a promising option. This role involves translating medical records into standardized codes essential for billing and data analysis.

Health information management is another critical field supporting the medical industry, focusing on patient data and healthcare systems optimization. Individuals can explore the best online health information management degree CAHIIM accredited programs to gain credentials recognized nationwide.

Professionals aiming for leadership roles may seek the qualifications to become a health information manager salary reflects the growing demand for those skilled in managing healthcare data and compliance.

For a quicker entry into healthcare support roles, accelerated courses are available. Students can consider enrolling in an accelerated medical billing and coding certificate online program to rapidly gain essential skills and certifications needed for employment.

Best Scientists Citing Rodolphe Thiébaut

Trending Scientists